Title:Evolving Treatment Paradigms for HPV-Related Oropharynx Cancer
Volume: 10
Issue: 4
Author(s): Allen M. Chen, Deborah Wong and Maie St. John
Affiliation:
Keywords:
Cancer, head and neck, HPV, radiation, squamous cell.
Abstract: It is now well-established that human papillomavirus (HPV)-associated squamous cell carcinoma,
which comprises an increasing proportion of all oropharyngeal cancers, represents a unique entity with distinct
clinical and molecular characteristics. Data also has emerged demonstrating that patients with HPVpositive
head and neck cancer have an improved prognosis compared to their HPV-negative counterparts,
with several series showing that patients with HPV-related tumors arising from the oropharynx have at least
half the risk of death. However, these studies have been complicated by such factors as the limited quality of
data, small sample sizes, as well as the variability in treatment, inclusion criteria, and follow-up. Although the
exact reason for the improved survival among HPV-positive patients is unclear, many investigators have proposed
that HPV-related head and neck cancer is more sensitive to the effects of radiation therapy than HPVnegative
tumors arising in the setting of traditional environmental exposures. Despite the attractiveness of this
hypothesis, the data focusing on possible de-intensification approaches remains preliminary, and treatment
paradigms will likely continue to evolve as findings from innovative clinical trials yield answers to many provocative
questions.
